Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RFA and FOLFOX4 for Recurrent HCC
NCT02426450Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Apr 2015
- Primary completion
- Oct 2015
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, fluorouracil, folinic acid in hepatocellular carcinoma (HCC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02426450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02426450.